Abstract
In epilepsy research, animal models serve a variety of purposes. First, they are used in the search for new antiepileptic drugs. Second, once the anticonvulsant activity of a novel compound has been detected, animal models are used to evaluate the possible specific efficacies of the compound against different types of seizures or epilepsy. Third, animal models can be used to characterize the preclinical efficacy of novel compounds during chronic administration. Such chronic studies can serve different objectives, for instance, evaluation of whether drug efficacy changes during prolonged treatment, e.g. because of the development of tolerance, or examination of whether a drug exerts antiepilep-togenic effects during prolonged administration, i.e. is a true antiepileptic drug. Fourth, animal models are employed to characterize the mechanism of action of old and new antiepileptic drugs. Fifth, certain models can be used to study mechanisms of drug resistance in epilepsy. Sixth, in view of the possibility that chronic brain dysfunction, such as epilepsy, might lead to altered sensitivity to drug adverse effects, models involving epileptic animals are useful to study whether epileptogenesis alters the adverse effect potential of a given drug. Seventh, animal models are needed for studies on the pathophysiology of epilepsies and epileptic seizures, e.g. the processes involved in epileptogenesis and ictogenesis (Lothman 1996a).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adamec RE (1990) Does kindling model anything clinically relevant? Biol Psychiatry 27:249–279
Albright PS (1983) Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex. Exp Neurol 79:11–17
Allen KM, Walsh C (1996) Shaking down new epilepsy genes. Nature Med 2:516–518
Bickford RG, Klass DW (1969) Sensory precipitation and reflex mechanisms. In: Jasper HH, Ward AAJ, Pope A (eds) Basic mechanisms of the epilepsies. Little Brown, Boston, pp. 543–564
Browning RA, Nelson DK (1985) Variation in threshold and pattern of electroshock-induced seizures in rats depending on site of stimulation. Life Sci 37:2205–2211
Chapman AG, Croucher MJ, Meldrum BS (1984) Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneim-Forsch 34:1261–1270
Chapman AG, Graham JL, Patel S, Meldrum BS (1991) Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Epilepsia 32:578–587
Coenen AML, Drinkenburg WHIM, Inoue M, van Luijtelaar ELJM (1992) Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res 12:75–86
Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489–501
Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399
Consroe P, Wolkin A (1977) Cannabidinol — antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther 201:26–32
Consroe P, Piccione A, Chin L (1979) Audiogenic seizure susceptible rats. Fed Proc 38:2411–2416
Craig CR, Colasanti BK (1988) A study of pentylenetetrazol kindling in rats and mice. Pharmacol Biochem Behav 31:867–870
Craig CR, Colasanti BK (1992) Cobalt-induced focal seizures: neuronal networks and actions of antiepileptic drugs. In: Faingold CL, Fromm GH (eds) Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. CRC Press, Boca Raton, pp. 125–142
Crawford RD (1969) A new mutant causing epileptic seizures in domestic fowl. Poultry Sci 48:1799
Czuczwar SJ, Frey H-H, Löscher W (1985) Antagonism of N-methyl-D,L-aspartic acid induced by antiepileptic drugs and other agents. Eur J Pharmacol 108:273–280
Dailey JW, Jobe PC (1985) Anticonvulsant drugs and the genetically epilepsy-prone rat. Fed Proc 44:2640–2644
Dalby NO, Nielsen EB (1997) Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 28:63–72
Dam M (1992) Localization related epileptic syndromes. In: Trimble MR, Bolwig TG (eds) The temporal lobes and the limbic system. Wrightson Biomedical Publishing, Petersfield, pp. 115–128
Dreifuss FE (1994) The international classification of seizures and epilepsies: advantages. In: Wolf P (ed) Epileptic seizures and syndromes. Libbev, London, pp. 9–14
Edmonds HL Jr, Bellin SI, Mia Chen F-C, Hegreberg GA (1978) Anticonvulsant properties of rozipine in epileptic and nonepileptic beagle dogs. Epilepsia 19:139–146
Empson RM, Amitai Y, Jefferys JG, Gutnick MJ (1993) Injection of tetanus toxin into the neocortex elicits persistent epileptiform activity but only transient impairment of GABA release. Neuroscience 57:235–239
Engel JJ (1992) Experimental models of epilepsy: classification and relevance to human epileptic phenomena. In: Avanzini G, Engel JJ, Fanello R, Heinemann U (eds) Neurotransmitters in epilepsy. Elsevier, Amsterdam, pp. 9–20
Engel JJ, Cahan L (1986) Potential relevance of kindling to human partial epilepsy. In: Wada JA (ed) Kindling 3. Raven Press, New York, pp. 37–51
Faingold CL, Fromm GH (1992) Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. CRC Press, Boca Raton
Faingold CL, Narikotu DK (1992) The genetically epilepsy-prone rat: neuronal networks and actions of amino acid neurotransmitters. In: Faingold CL, Fromm GH (eds) Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. CRC Press, Boca Raton, pp. 277–308
Fisher RS (1989) Animal models of the epilepsies. Brain Res Rev 14:245–278
Frankel WN, Taylor BA, Noebels JL, Lutz CM (1994) Genetic epilepsy model derived from common inbred mouse strains. Genetics 138:481–489
Gastaut H, Gastaut JL, Geucalves CE, Silva CE, Fernandez Sanchez JL (1975) Relative frequency of different types of epilepsy: a study employing the classification of the international league against epilepsy. Epilepsia 16:457–467
Gladding GD, Kupferberg HJ, Swinyard EA (1985) Antiepileptic drug development program. In: Frey H-H, Janz D (eds) Antiepileptic drugs. Springer-Verlag, Berlin, pp. 341–350
Goddard GV, McIntyre DC, Leech CK (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295–330
Hauser WA, Annegers JF, Kurland LT (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 34:453–468
Heinemann U, Draguhn A, Ficker E, Stabel J, Zhang CL (1994) Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia 35 [Suppl 5]:S10–S21
Heller AH, Dichter MA, Sidman RL (1983) Anticonvulsant sensitivity of absence seizures in the tottering mutant mouse. Epilepsia 25:25–34
Hernandez TD (1997) Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis. Trends Neurosci 18:59–620
Hoogerkamp A, Vis PW, Danhof M, Voskuyl RA (1994) Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat. J Pharmacol Exp Ther 269:521–528
Hosford DA, Wang Y (1997) Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 38:408–414
Hosford DA, Clark S, Cao Z, Wilson WAJ, Fu-hsiung L, Morrisett RA, Huin A (1992) The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257:398–401
Hosford DA, Wang Y, Liu CC, Snead OC (1995) Characterization of the antiabsence effects of SCH 50911, a GABAB antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models. J Pharmacol Exp Ther 274:1399–1403
Hönack D, Löscher W (1995) Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 36:763–771
Jobe PC, Mishra PK, Dailey JW (1992) Genetically epilepsy-prone rats: actions of antiepileptic drugs and monoaminergic neurotransmitters. In: Faingold CL, Fromm GH (eds) Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. CRC Press, Boca Raton, pp. 253–275
Killam EK (1979) Photomyoclonic seizures in the baboon. Fed Proc 38:2429–2433
Killam KF, Killam EK, Naquet RJ (1966) Mise en evidence chez certains singels d’un syndrome photomyoclonique. Can R Acad Sci 262:1010–1212
Killam KF, Killam EK, Naquet RJ (1967) An animal model of light sensitive epilepsy. Electroencephalogr Clin Neurophysiol 22:497–513
Killam EK, Matsuzaki M, Killam KF (1973) Effects of chronic administration of benzodiazepines on epileptic seizures and brain electrical activity in Papio papio. In: Garratini S, Mussini E, Randall LO (eds) Benzodiazepines. Raven Press, New York, pp. 443–460
King JT, LaMotte CC (1989) El mouse as a model of focal epilepsy: a review. Epilepsia 30:257–265
Koella WP (1985) Animal experimental methods in the study of antiepileptic drugs. In: Frey H-H, Janz D (eds) Antiepileptic drugs. Springer, Berlin, pp. 283–350
Kostopoulos GK (1992) The tottering mouse: a critical review of its usefulness in the study of the neuronal mechanisms underlying epilepsy. J Neural Transm 35 [Suppl]:21–36
Krall RL, Penry JK, Kupferberg HJ, Swinyard EA (1978a) Antiepileptic drug development: I. History and a program for progress. Epilepsia 19:393–408
Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978b) Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19:409–428
Krupp E, Löscher W (1998) Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models. J Pharmacol Exp Ther 285:1137–1149
Laird H, Consroe P, Straussner A (1976) Anticonvulsant drug comparisons in audiogenic and nonaudiogenic rats. Pharmacologist 18:136
Leite JP, Cavalheiro EA (1995) Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20:93–104
Leppik IE (1992) Intractable epilepsy in adults. In: Theodore WH (ed) Surgical treatment of epilepsy. Elsevier, Amsterdam, pp. 7–11
Levy RH, Mattson RH, Meldrum BS (1995) Antiepileptic drugs. 4th edn, Raven Press, New York
Lewin E (1972) The production of epileptogenic cortical foci in experimental animals by freezing. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy — A manual for the laboratory worker. Raven Press, New York, pp. 37–50
Loiseau P (1986) Intractable epilepsy: prognostic evaluation. In: Schmidt D, Morselli PL (eds) Intractable epilepsy: experimental and clinical aspects. Raven Press, New York, pp. 227–258
Löscher W (1981) Plasma levels of valproic acid and its metabolites during continued treatment in dogs. J Vet Pharmacol Ther 4:111–119
Löscher W (1984) Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review. Methods Findings Experiment Clin Pharmacol 6:531–547
Löscher W (1986) Experimental models for intractable epilepsy in nonprimate animal species. In: Schmidt D, Morselli PL (eds) Intractable epilepsy: experimental and clinical aspects. Raven Press, New York, pp. 25–37
Löscher W (1991) The epileptic gerbil. Neuronal networks and actions of antiepileptic drugs. In: Faingold CL, Fromm GH (eds) Drugs for control of epilepsy. CRC Press, Boca Raton, pp. 309–323
Löscher W (1992) Genetic animal models of epilepsy. In: Driscoll P (ed) Genetically defined animal models of neurobehavioral dysfunctions. Birkhäuser, Boston, pp. 111–135
Löscher W (1993) Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 18:485–502
Löscher W (1994) Neue Antiepileptika — ein Fortschritt für die Behandlung epileptischer Tiere? Kleintierpraxis 39:325–342
Löscher W (1997) Animal models of intractable epilepsy. Prog Neurobiol (in press)
Löscher W, Ebert U (1996) Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy. Epilepsy Res 11 [Suppl]:17–44
Löscher W, Fiedler M (1996) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res 25:3–10
Löscher W, Rundfeldt C (1991) Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J Pharmacol Exp Ther 258:483–489
Löscher W, Hönack D (1991) Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol Sci 12:52
Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145–181
Löscher W, Schmidt D (1993) New drugs for the treatment of epilepsy. Curr Opin Invest Drugs 2:1067–1095
Löscher W, Schmidt D (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17:95–134
Löscher W, Schwartz-Porsche D, Frey H-H, Schmidt D (1985) Evaluation of epileptic dogs as an animal model of human epilepsy. Arzneim-Forsch 35:82–87
Löscher W, Fassbender CP, Nolting B (1991a) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8:79–94
Löscher W, Hönack D, Fassbender CP, Nolting B (1991b) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models. Epilepsy Res 8:171–189
Loskota WJ, Lomax P (1975) The Mongolian gerbil (Meriones unguiculatus) as a model for the study of the epilepsies: EEG records of seizures. Electroencephalogr Clin Neurophysiol 38:597–604
Lothman EW (1996a) Neurobiology as a basis for rational polypharmacy. Epilepsy Res [Suppl] 11:3–7
Lothman EW (1996b) Basis mechanisms of seizure spread. Epilepsy Res [Suppl] 11:9–16
Lothman EW, Bertram EH (1993) Epileptogenic effects of status epileptics. Epilepsia 34 [Suppl]:S59–S70
Lothman EW, Bertram EH, Kapur J, Stringer JL (1990) Recurrent spontaneous hip-pocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res 6:110–118
Lothman EW, Williamson JM, Van Landingham KE (1991) Intraperitoneal phenytoin suppresses kindled responses: effects on motor and electrographic seizures. Epilepsy Res 9:11–18
Marescaux C, Vergnes M, Depaulis A (1992) Genetic absence epilepsy in rats from Strasbourg — A review. J Neural Transm 35:37–69
Mattson RH (1995) Selection of antiepileptic drug therapy. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic drugs. 4th edn, Raven Press, New York, pp. 123–136
McNamara JO (1984) Kindling: an animal model of complex partial epilepsy. Ann Neurol 16 [Suppl]:S72–S76
McNamara JO, Rigsbee LC, Butler LS, Shin C (1989) Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann Neurol 26:675–678
Meldrum B (1996) Action of established and novel anticonvulsant drugs on the basic mechanisms of epilepsy. Epilepsy Res 11 [Suppl]:67–78
Naquet R, Meldrum BS (1972) Photogenic seizures in baboon. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy — A manual for the laboratory worker, Raven Press, New York, pp. 373–406
Noebels JL (1979) Analysis of inherited epilepsy using single locus mutations in mice. Fed Proc 38:2405–2410
Noebels JL (1986) Mutational analysis of inherited epilepsies. In: Delgado-Escueta AV, Ward AA, Woodbury DM, Porter RJ (eds) Basic mechanisms of epilepsies. Molecular and cellular approaches. Raven Press, New York, pp. 97–114
Noebels JL (1996) Using genes to create new models of epilepsy. Epilepsia 37 [Suppl 5]:2
Noebels JL, Sidman RL (1979) Inherited epilepsy: spike-wave and focal motor seizure in mutant mouse tottering. Science 204:1334–1336
Piredda SG, Woodhead JH, Swinyard EA (1985) Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide, and valproate. J Pharmacol Exp Ther 232:741–745
Prince DA (1972) Topical convulsant drugs and metabolic antagonists. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy — A manual for the laboratory worker. Raven Press, New York, pp. 51–84
Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (1972) Experimental models of epilepsy — A manual for the laboratory worker. Raven Press, New York
Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph Clin Neurophysiol 32:281–294
Racine RJ, Ivy GO, Milgram NW (1989) Kindling: clinical relevance and anatomical substrate. In: Bolwig TG, Trimble MR (eds) The clinical relevance of kindling. Wiley, Chichester, pp. 15–34
Reynolds EH (1989) The process of epilepsy: is kindling relevant? In Bolwig TG, Trimble MR (eds) The clinical relevance of kindling. Wiley, Chichester, pp. 149– 160
Rinne SP, Bowyer JF, Barrows EB, Killam EK (1978) EEG effects of ethosuximide in Papio papio. Pharmacologist 20:161
Rise ML, Frankel WN, Coffin JM, Seyfried TN (1991) Genes for epilepsy mapped in the mouse. Science 253:669–673
Rundfeldt C, Hönack D, Löscher W (1990) Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 29:845–851
Sasa M, Ohno Y, Ujihara H, Fujita Y, Yoshimura M, Takaori S, Serikawa T, Yamada J (1988) Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat. Epilepsia 29:505–513
Sato M, Racine RJ, McIntyre DC (1990) Kindling: basic mechanisms and clinical validity. Electroenceph Clin Neurophysiol 76:459–472
Schmidt J (1987) Changes in seizure susceptibility in rats following chronic administration of pentylenetetrazol. Biomed Biochem Acta 46:267–270
Schmidt D (1993) Epilepsien und epileptische Anfälle. Thieme Verlag, Stuttgart
Serikawa T, Yamada J (1986) Epileptic seizures in rats homozygous for two mutations, zitter and tremor. J Hered 77:441–444
Seyfried TN (1979) Audiogenic seizures in mice. Fed Proc 38:2399–2404
Seyfried TN, Glaser GH (1985) A review of mouse mutants as genetic models of epilepsy. Epilepsia 26:143–150
Snead OC (1992) Pharmacological models of generalized absence seizures in rodents. J Neural Transm 35 [Suppl]:7–19
Speciale J, Dayrell-Hart B, Steinberg SA (1991) Clinical evaluation of gamma-vinyl-gamma-aminobutyric acid for control of epilepsy in dogs. J Am Vet Med Assoc 198:995–1000
Sperk G (1994) Kainic acid seizures in the rat. Progr Neurobiol 42:1–32
Stark LG, Killam KF, Killam EK (1970) The anticonvulsant effects of phenobarbitone, diphenylhydantoin and two benzodiazepines in the baboon, Papio papio. J Pharmacol Exp Ther 173:125–132
Stumpf C (1962) Pharmakologische Methoden. In: Stumpf C, Petschke H (eds) Erzeugung von Krankheitszuständen durch das Experiment: Zentralnervensystem. Springer-Verlag, Berlin, pp. 1–105
Suzuki J, Nakamoto Y (1978) Sensory precipitation epilepsy focus in El mice and Mongolian gerbils. Folia Psychiat Neurol Jpn 32:349–350
Sveinsbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165–174
Swinyard EA (1949) Laboratory assay of clinically effective antiepileptic drugs. J Am Pharm Assoc 38:201–204
Swinyard EA (1969) Laboratory evaluation of antiepileptic drugs. Review of laboratory methods. Epilepsia 10:107–119
Swinyard EA (1972) Electrically induced convulsions. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy — A manual for the laboratory worker. Raven Press, New York, pp. 433–458
Swinyard EA, Brown WC, Goodman LS (1952) Comparative assay of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106:319–330
Swinyard EA, Wolf HH, White HS, Skeen GA, Stark LG, Albertson T, Pong SF, Drust EG (1993) Characterization of the anticonvulsant properties of F-721. Epilepsy Res 15:35–45
Trimble MR (1991) Epilepsy and behaviour. Epilepsy Res 10:71–79
Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA (1989) Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel model of intractable epilepsy. Synapse 3:154–171
Voskuyl RA, Dingemanse J, Danhof M (1989) Determination of the threshold for convulsions by direct cortical stimulation. Epilepsy Res 3:120–129
Voskuyl RA, Hoogerkamp A, Danhof M (1992) Properties of the convulsive threshold determined by direct cortical stimulation in rats. Epilepsy Res 12:111–120
Ward AAJ (1972) Topical convulsant metals. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy — A manual for the laboratory worker. Raven Press, New York, pp. 13–36
White HS, Woodhead JH, Franklin MR, Swinyard EA, Wolf HH (1995) Experimental selection, quantification, and evaluation of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic drugs. 4th edn, Raven Press, New York, pp. 99–110
Williams SF, Colling SB, Whittington MA, Jefferys JG (1993) Epileptic focus induced by intrahippocampal cholera toxin in rat: time course and properties in vivo and in vitro. Epilepsy Res 16:137–146
Woodbury DM (1972) Applications to drug evaluations. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy — A manual for the laboratory worker. Raven Press, New York, pp. 557–584
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Löscher, W. (1999). Animal Models of Epilepsy and Epileptic Seizures. In: Eadie, M.J., Vajda, F.J.E. (eds) Antiepileptic Drugs. Handbook of Experimental Pharmacology, vol 138. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60072-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-60072-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64244-9
Online ISBN: 978-3-642-60072-2
eBook Packages: Springer Book Archive